Skip to content
PubMed This is a summary of 11 peer-reviewed journal articles Updated
Pediatrics · Proprotein Convertase 1/3 Deficiency

Understanding PCSK1 Deficiency: A Guide for Parents and Caregivers

At a Glance

PCSK1 deficiency is a rare genetic disorder that may cause severe infant diarrhea and poor growth, followed by intense hunger and obesity. Care focuses on nutrition, hormone and blood sugar monitoring, and treatments such as setmelanotide for eligible patients.

If you have spent months or even years searching for answers while your child struggled with severe digestive issues and then sudden weight gain, finally receiving a diagnosis of PCSK1 deficiency can bring a complicated mix of emotions. It is a diagnosis that validates everything you have witnessed: the confusing shift from a child who struggled to absorb nutrients to one who can never seem to get enough.

An Exceptionally Rare Condition

It is completely normal if your local pediatrician or family doctor has never seen a case of PCSK1 deficiency. This condition is extraordinarily rare; in fact, the medical literature has historically reported only a very small number of molecularly confirmed cases worldwide (fewer than 40 in some published case reviews, though this may be an underestimate due to underdiagnosis) [1].

Because it is so rare and its symptoms change so much over time, it is frequently missed or mistaken for other digestive or metabolic disorders [2]. Many families go through a long and exhausting “diagnostic odyssey” before a genetic test finally provides the answer. Having a name for what your child is experiencing is not just a label—it is the first step toward a management plan tailored to their unique biology.

The “Protein-Cutting” Enzyme: PC1/3

To understand this condition, it helps to think of the body as a factory that produces “pre-packaged” hormones. These hormones are created in large, inactive forms that need to be cut into smaller, active pieces before they can do their jobs.

Proprotein convertase 1/3 (PC1/3)—the enzyme encoded by the PCSK1 gene—acts like the biological “scissors” responsible for this cutting [3]. Without these “scissors,” the body cannot activate several vital hormones that regulate:

  • Digestion and nutrient absorption [4].
  • Appetite and the feeling of being full (satiety) [5].
  • Blood sugar and insulin levels [6].
  • Growth and other hormone systems, such as the thyroid and adrenal glands [7].

When the PC1/3 enzyme is missing or not working correctly, these inactive hormones build up in the body, while the active versions the body needs are in short supply [6].

The Two Phases of PCSK1 Deficiency

The clinical course is highly variable, but many families experience a biphasic (two-phase) presentation.

Phase 1: Early Digestive Struggles

Shortly after birth or during the first weeks of life, many infants with this condition develop severe, watery malabsorptive diarrhea—diarrhea that occurs because the body cannot properly break down and absorb nutrients from food [3][6].

During this phase, the primary goal is often just to keep the child hydrated and growing. Many infants require parenteral nutrition (feeding through a vein) or highly specialized formulas because their intestines cannot process standard nutrition [6][4]. This phase can be terrifying for parents as they struggle with their child’s “failure to thrive” and frequent hospitalizations for dehydration or metabolic imbalances [7].

Phase 2: Rapid Growth and Intense Hunger

As children move out of infancy, the digestive issues often begin to stabilize, but a new challenge emerges for many: hyperphagia (an intense, insatiable hunger) and rapid weight gain [4]. In small published cohorts, early-onset obesity was a common finding, sometimes starting in the early years of life [7].

This is not a matter of “willpower” or parenting. Because the body cannot activate the hormones that tell the brain it is full, the child’s brain constantly signals a drive to eat [5]. This shift can be jarring for parents who spent the first year of their child’s life desperately trying to get them to eat and gain weight.

Beyond Weight and Digestion

Because PC1/3 affects so many different hormones, other symptoms often appear over time. These are not failures of the child’s body, but direct results of the missing enzyme:

  • Hormone Deficiencies: Many children develop issues with growth hormone, thyroid function, or the body’s stress response (adrenal function) [7].
  • Blood Sugar Issues: The body struggles to process insulin correctly. This can lead to high proinsulin levels (the inactive form of insulin) and may eventually cause diabetes or episodes of low blood sugar [7][8].
  • Thirst and Hydration: Some children develop central diabetes insipidus, leading to extreme thirst and frequent urination [7].

Managing the Path Ahead

While there is currently no way to replace the missing PC1/3 enzyme directly, care focuses on managing the specific symptoms as they arise. This typically involves a multidisciplinary team of specialists, including gastroenterologists and endocrinologists [4].

For the obesity phase, traditional lifestyle changes alone are often ineffective because they do not address the underlying hormonal hunger [9]. However, newer treatments like setmelanotide are now approved in several countries for eligible patients with genetically confirmed biallelic PCSK1 deficiency to help regulate the brain’s hunger signals [10][11]. Regular monitoring of hormone levels and blood sugar is essential to catch and treat new symptoms as they emerge throughout childhood [7].

Common questions in this guide

What symptoms can PCSK1 deficiency cause in infants?
Many affected infants develop severe watery diarrhea because they cannot properly digest and absorb nutrients. Dehydration, poor growth, metabolic imbalances, and the need for specialized nutrition can occur, although the exact course varies.
Why does PCSK1 deficiency lead to extreme hunger and weight gain?
PC1/3 normally helps activate hormones that signal fullness to the brain. When it is missing or does not work properly, a child may experience hyperphagia, or persistent intense hunger, and rapid weight gain that is not simply a matter of willpower or parenting.
What other hormone problems can happen with PCSK1 deficiency?
PCSK1 deficiency can affect growth hormone, thyroid function, the adrenal stress response, insulin processing, and blood sugar. Some children also develop central diabetes insipidus, which can cause marked thirst and frequent urination.
How is PCSK1 deficiency confirmed?
Doctors may recognize the pattern of early malabsorptive diarrhea followed by hyperphagia and weight gain, then use genetic testing to confirm disease-causing changes in the PCSK1 gene. Testing and interpretation should be handled by a specialist team because symptoms and severity vary.
Is there a treatment for obesity caused by PCSK1 deficiency?
There is no direct replacement for the missing PC1/3 enzyme, so care is tailored to nutrition, hunger, hormones, and blood sugar. Setmelanotide may be an option in countries where it is approved for eligible patients with genetically confirmed biallelic PCSK1 deficiency.
Which specialists should care for a child with PCSK1 deficiency?
Care often involves a multidisciplinary team, especially a gastroenterologist for digestive and nutrition problems and an endocrinologist for hormones, appetite, and blood sugar. Regular monitoring helps the team identify new hormone or glucose problems as the child grows.

Get notified when new evidence is published on Obesity due to prohormone convertase I deficiency.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.

References

References (11)
  1. 1

    Pathogenic Deep Intronic PCSK1 Variant Causes Proprotein Convertase 1/3 Deficiency in a Family.

    Huber LM, Subaşıoğlu A, Garczarczyk-Asim D, et al.

    Clinical genetics 2025; (108(1)):102-106 doi:10.1111/cge.14717.

    PMID: 39891480
  2. 2

    Enteroendocrine Dysfunction in Two Saudi Sisters.

    Ahmed ABM, Alsaleem BMR

    Case reports in gastroenterology 2021; (15(1)):290-295 doi:10.1159/000511761.

    PMID: 33790717
  3. 3

    PCSK1 Variants and Human Obesity.

    Ramos-Molina B, Martin MG, Lindberg I

    Progress in molecular biology and translational science 2016; (140()):47-74.

    PMID: 27288825
  4. 4

    A novel mutation of PCSK1 responsible for PC1/3 deficiency in two siblings.

    Duclaux-Loras R, Bourgeois P, Lavrut PM, et al.

    Clinics and research in hepatology and gastroenterology 2021; (45(6)):101640 doi:10.1016/j.clinre.2021.101640.

    PMID: 33662777
  5. 5

    PC1/3 Deficiency Impacts Pro-opiomelanocortin Processing in Human Embryonic Stem Cell-Derived Hypothalamic Neurons.

    Wang L, Sui L, Panigrahi SK, et al.

    Stem cell reports 2017; (8(2)):264-277 doi:10.1016/j.stemcr.2016.12.021.

    PMID: 28132887
  6. 6

    Novel Homozygous Inactivating Mutation in the PCSK1 Gene in an Infant with Congenital Malabsorptive Diarrhea.

    Aerts L, Terry NA, Sainath NN, et al.

    Genes 2021; (12(5)) doi:10.3390/genes12050710.

    PMID: 34068683
  7. 7

    A New Case of PCSK1 Pathogenic Variant With Congenital Proprotein Convertase 1/3 Deficiency and Literature Review.

    Pépin L, Colin E, Tessarech M, et al.

    The Journal of clinical endocrinology and metabolism 2019; (104(4)):985-993 doi:10.1210/jc.2018-01854.

    PMID: 30383237
  8. 8

    A case of prohormone convertase deficiency diagnosed with type 2 diabetes.

    Karacan Küçükali G, Savaş Erdeve Ş, Çetinkaya S, et al.

    Turkish archives of pediatrics 2021; (56(1)):81-84 doi:10.14744/TurkPediatriArs.2020.36459.

    PMID: 34013237
  9. 9

    Natural History of Obesity Due to POMC, PCSK1, and LEPR Deficiency and the Impact of Setmelanotide.

    Wabitsch M, Farooqi S, Flück CE, et al.

    Journal of the Endocrine Society 2022; (6(6)):bvac057 doi:10.1210/jendso/bvac057.

    PMID: 35528826
  10. 10

    Management of Monogenic and Syndromic Obesity.

    Han JC, Rasmussen MC, Forte AR, et al.

    Gastroenterology clinics of North America 2023; (52(4)):733-750 doi:10.1016/j.gtc.2023.08.005.

    PMID: 37919024
  11. 11

    Setmelanotide in patients aged 2-5 years with rare MC4R pathway-associated obesity (VENTURE): a 1 year, open-label, multicenter, phase 3 trial.

    Argente J, Verge CF, Okorie U, et al.

    The lancet. Diabetes & endocrinology 2025; (13(1)):29-37 doi:10.1016/S2213-8587(24)00273-0.

    PMID: 39549719

This page provides general information about PCSK1 deficiency and does not constitute medical advice. Your child's gastroenterologist and endocrinologist can interpret your child's symptoms, hormone tests, and treatment options.